Case Digest (A.C. No. 8000)
Facts:
In Dr. Rubi Li v. Spouses Reynaldo and Lina Soliman (G.R. No. 165279, June 7, 2011), an 11-year-old girl, Angelica Soliman, was diagnosed on July 7, 1993 with osteosarcoma, a highly malignant bone cancer, after biopsy at St. Luke’s Medical Center (SLMC). Her right leg was amputated by Dr. Jaime Tamayo, who recommended adjuvant chemotherapy to eliminate residual cancer cells. He referred Angelica to petitioner Dr. Rubi Li, a board-certified oncologist. On August 18, 1993, Angelica was readmitted to SLMC and on August 19 petitioner began a chemotherapy regimen with Cisplatin, Doxorubicin, and Cosmegen. Angelica’s condition deteriorated over the next 13 days with vomiting, rashes, breathing difficulty, bleeding and convulsions; she died on September 1, 1993. The PNP Crime Laboratory’s medico-legal report attributed death to “hypovolemic shock secondary to multiple organ hemorrhages and disseminated intravascular coagulation,” while SLMC’s death certificate cited osteosarcoma and chCase Digest (A.C. No. 8000)
Facts:
- Diagnosis and Initial Treatment
- On July 7, 1993, respondents’ 11-year-old daughter Angelica was diagnosed with osteosarcoma, osteoblastic type, after a biopsy at St. Luke’s Medical Center (SLMC).
- On July 23, 1993, Dr. Jaime Tamayo amputated Angelica’s right leg above the knee as primary intervention against the malignant tumor.
- Referral and Chemotherapy
- Dr. Tamayo referred Angelica to Dr. Rubi Li, a medical oncologist at SLMC, for adjuvant chemotherapy to eliminate residual cancer cells and prevent metastasis.
- Angelica was readmitted on August 18, 1993; the first cycle of intravenous chemotherapy (Cisplatin, Doxorubicin, Cosmegen) began on August 19; she died on September 1, 1993, eleven days after treatment commenced.
- Cause of Death Reports
- SLMC Death Certificate listed cause as “Osteosarcoma, status post AKA, status post chemotherapy.”
- PNP Crime Laboratory autopsy determined death by “Hypovolemic shock secondary to multiple organ hemorrhages and Disseminated Intravascular Coagulation (DIC).”
- Civil Proceedings
- On February 21, 1994, respondents sued Dr. Li, Dr. Leo Marbella, SLMC and others for negligence in administering chemotherapy and for failure to obtain informed consent.
- At trial, key witnesses included respondents, Dr. Li, Dr. Tamayo, Dr. Jesusa Vergara (PNP Medico-Legal Officer) and Dr. Melinda Balmaceda (DOH Medical Specialist).
- Trial Court and CA Decisions
- The Regional Trial Court dismissed the complaint, finding Dr. Li non-negligent in chemotherapy administration and professionally competent.
- The Court of Appeals modified, holding Dr. Li negligent for not fully disclosing serious side effects before securing consent and awarded actual, moral and exemplary damages plus fees.
Issues:
- Did Dr. Li commit medical negligence in administering chemotherapy to Angelica?
- Did Dr. Li fail to sufficiently disclose material risks and side effects of chemotherapy, thus breaching the doctrine of informed consent?
- If disclosure was inadequate, did that failure proximately cause consent to treatment and Angelica’s resulting death and respondents’ damages?
Ruling:
- (Subscriber-Only)
Ratio:
- (Subscriber-Only)
Doctrine:
- (Subscriber-Only)